Patents Examined by Steven Pohnert
  • Patent number: 12286675
    Abstract: The present invention relates to a method, in particular an in vitro method, for identifying CD3CD4 positive T lymphocytes of a mammal, wherein said method comprises analysing the methylation status of at least one CpG position in the CD3a/b/c/d/g genes, in particular their “upstream” regulatory regions, and in particular the promoter and other conserved regions of the gene cd3, wherein a demethylation of at least one CpG in the analyzed sample to at least 90% is indicative for memory and naive CD4 or/and memory and/or naive T lymphocytes. Furthermore, the present invention is directed at the use of DNA-methylation analysis of the genes CD3a/b/c/d for the detection and quality assurance and control of T lymphocytes. Furthermore, the present invention relates to a kit for performing the above methods as well as respective uses thereof.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: April 29, 2025
    Assignee: Precision for Medicine GmbH
    Inventors: Sven Olek, Ivana Turbachova
  • Patent number: 12281353
    Abstract: Biosensors for detection terephthalic acid (TPA) and methods of their use are provided. The biosensors include a nucleic acid encoding a TphR protein, a promoter regulated by TPA, and a reporter operably linked to the promoter. Vectors and host cells including the biosensors are also provided.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: April 22, 2025
    Assignees: TRIAD NATIONAL SECURITY, LLC, UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Inventors: Ramesh K. Jha, Taraka T. Dale, Ryan E. Bermel, Ellen Lee Neidle
  • Patent number: 12216121
    Abstract: Described herein are nucleic acid molecules and complexes useful for spatiotemporally mapping intra-endosmal thiol disulphide exchange. Aspects of the disclosure relate to a composition comprising a first nucleic acid conjugated to a normalization moiety; and a second nucleic acid conjugated to a catalytic substrate; wherein reaction of the substrate with a catalyst produces a detectable product; and wherein the first and second nucleic acids are complementary or substantially complementary. Further aspects relate to a composition comprising: a first nucleic acid conjugated to a normalization moiety and to a catalytic substrate; and a second nucleic acid; wherein reaction of the substrate with a catalyst produces a detectable product; and wherein the first and second nucleic acids are complementary or substantially complementary.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: February 4, 2025
    Assignee: THE UNIVERSITY OF CHICAGO
    Inventors: Yamuna Krishnan, Krishna Dan, Aneesh T. Veetil, Kasturi Chakraborty
  • Patent number: 12188009
    Abstract: Methods for simplified, rapid gel electrophoresis size-purification and downstream sequencing of an Oligo Library, for example an miRNA Library, based on co-purifying a DNA ladder molecular weight standard customized to co-migrate with Library to provide highly salient bands on the gel at the upper and lower ends of the Library size range, permitting precise cutting and avoiding the negative effects of gel distortion, variation of DNA migration rate in different lanes, and the difficulty of matching sample to ladder across a large distance. The methods may be applied to increase yield and purity in an Oligo Library of low-quality or low input Oligo, and in particular in small RNA samples.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: January 7, 2025
    Assignee: University of Cincinnati
    Inventors: Xiang Zhang, Shuk-Mei Ho
  • Patent number: 12188929
    Abstract: Disclosed herein are highly sensitive immunoassays that utilize a capture/release mechanism to reduce non-specific binding and achieve detection with attomolar-level sensitivity. Kits that can be used for carrying out these highly sensitive immunoassays are also disclosed herein.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: January 7, 2025
    Assignee: Alamar Biosciences, Inc.
    Inventors: Yuling Luo, Wei Feng, Adrian Grzybowski, Yiyuan Yin, Shiping Chen
  • Patent number: 12139751
    Abstract: The present disclosure relates in some aspects to methods and compositions for analysis of a target nucleic acid, such as in situ detection of a region of interest in a polynucleotide in a tissue sample. In some embodiments, provided herein are templated ligation probes (e.g., RNA-templated ligation probes) and selector probes for generation of a circularized ligated probe comprising an insertion sequence of a selector probe, wherein the circularized ligated probe is amplified in a rolling circle amplification reaction to generate a product that is detected in the sample.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: November 12, 2024
    Assignee: 10X GENOMICS, INC.
    Inventors: Jorge Iván Hernández Neuta, Malte Kühnemund, Jessica Östlin, Xiaoyan Qian, Toon Verheyen
  • Patent number: 12105084
    Abstract: Disclosed herein are highly sensitive immunoassays that utilize a capture/release mechanism to reduce non-specific binding and achieve detection with attomolar-level sensitivity. Kits that can be used for carrying out these highly sensitive immunoassays are also disclosed herein.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: October 1, 2024
    Assignee: Alamar Biosciences, Inc.
    Inventors: Yuling Luo, Wei Feng, Adrian Grzybowski, Yiyuan Yin, Shiping Chen
  • Patent number: 12084474
    Abstract: Embodiments of the present disclosure relate to methods of preparation of templates for polynucleotide sequencing. In particular, the disclosure relates to linearization of clustered polynucleotides in preparation for sequencing by cleavage of one or more first strands of double-stranded polynucleotides immobilized on a solid support by a transition metal complex, for example, a palladium complex or a nickel complex. Further disclosure relate to linearization of clustered polynucleotides by cleaving one or more second strands of double double-stranded polynucleotides immobilized on a solid support comprising azobenzene linker by Na2S2O4. Nucleotides and oligonucleotides comprising a 3? phosphate moiety blocking group, and methods of removing the same using a fluoride reagent are also disclosed.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: September 10, 2024
    Assignee: Illumina, Inc.
    Inventors: Xiaolin Wu, Randall Smith, Peyton Shieh, John M. Beierle, Wayne N. George, Elliot John Lawrence, Jie Mao, Xiaohai Liu
  • Patent number: 12018315
    Abstract: The present disclosure relates to a device, comprising a base and a plurality of microneedles attached to the base, wherein each microneedle has an outer surface; the outer surface of at least one microneedle being coated with a composition comprising at least one polymer and least one Peptide Nucleic Acid (PNA). The present disclosure additionally relates to a method of detecting an analyte in interstitial fluid (ISF), comprising contacting the device to a subject, for example, to human skin.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: June 25, 2024
    Assignees: Massachusetts Institute of Technology, Imperial College Innovations Limited
    Inventors: Darrell J. Irvine, Jason Y. H. Chang, Sylvain Ladame, Dana Al Sulaiman
  • Patent number: 11905552
    Abstract: A digital biosensor for assaying a target nucleic acid and methods of using the biosensor for digitally detecting the target nucleic acid are disclosed wherein the biosensor includes a substrate having a substrate surface and at least two electrodes, a linker molecule having a first moiety conjugated to the substrate surface, a ribonucleoprotein (RNP) conjugated to a second moiety of the linker molecule, and a guide ribonucleic acid (gRNA) having a first sequence capable of binding to the inactive RNP and a second sequence capable of binding to the target nucleic acid.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: February 20, 2024
    Assignees: KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Kiana Aran, Tara deBoer, Irina Conboy
  • Patent number: 11840730
    Abstract: Aspects of the invention relates to methods and compositions that are useful to reduce bias and increase the reproducibility of multiplex analysis of genetic loci. In some configurations, predetermined preparative steps and/or nucleic acid sequence analysis techniques are used in multiplex analyses for a plurality of genetic loci in a plurality of samples.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: December 12, 2023
    Assignee: MOLECULAR LOOP BIOSCIENCES, INC.
    Inventors: Gregory Porreca, Uri Laserson
  • Patent number: 11834720
    Abstract: Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant Staphylococcus aureus (MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: December 5, 2023
    Assignee: GENEOHM SCIENCES, INC.
    Inventors: Ann Huletsky, Richard Giroux
  • Patent number: 11788141
    Abstract: The present invention relates to a method, in particular an in vitro method, for identifying CD56+ NK cells, comprising analyzing the methylation status of at least one CpG position in the mammalian gene region for mevalonate (diphospho) decarboxylase (MVD), wherein a demethylation or lack of methylation of said gene region is indicative for a CD56+ NK cell, when compared to a non-CD56+ NK cell. The analyses according to the invention can identify CD56+ NK cells on an epigenetic level and distinguish them from all other cells in complex samples, such as, for example, other blood or immune cells. The present invention furthermore provides an improved method for quantifying CD56+ NK cells, in particular in complex samples. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: October 17, 2023
    Assignee: Precision for Medicine GmbH
    Inventor: Sven Olek
  • Patent number: 11781127
    Abstract: The present invention provides a method for the isolation of sperm DNA from swabs taken from rape victims without having to perform a change in buffers. Non-sperm cells from the victim are digested with an enzyme and solubilized, and then in the same buffer an enzyme capable of digesting soluble DNA is added and the victim's DNA is degraded, leaving only the rapist's DNA intact. Since no change of buffer is needed, no centrifugation or filtration steps are needed. The inventive method has utility particularly in the forensic science field.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: October 10, 2023
    Inventor: Alex Garvin
  • Patent number: 11781178
    Abstract: Provided herein are compositions and methods for the synthesis, amplification, and in vitro transcription of full-length cDNA, or cDNA fragments. Methods are provided for reverse transcription of RNA and amplification for in vitro transcription. Further provided are method for loading of dendritic cells with the RNA and homologous lysate for immune stimulation.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: October 10, 2023
    Assignee: Baylor College of Medicine
    Inventors: William K. Decker, Vanaja Konduri
  • Patent number: 11773458
    Abstract: Methods for the rapid detection of the presence or absence of BK virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting BK virus and kits are provided that are designed for the detection of BK virus.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: October 3, 2023
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Rochak Mehta, Jingtao Sun
  • Patent number: 11761041
    Abstract: The present invention relates to a method, in particular an in vitro method, for identifying monocytes, comprising analyzing the methylation status of at least one CpG position in the mammalian gene region for parkin RBR E3 ubiquitin protein ligase (PARK2), wherein a de-methylation or lack of methylation of said gene region is indicative for a monocyte, when compared to a non-monocyte cell. The analyses according to the invention can identify monocytes on an epigenetic level and distinguish them from all other cells in complex samples, such as, for example, other blood or immune cells. The present invention furthermore provides an improved method for quantifying monocytes, in particular in complex samples. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue. Also claimed are kits and specific oligonucleotides for use as primers or probes.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 19, 2023
    Assignee: Precision for Medicine GmbH
    Inventor: Sven Olek
  • Patent number: 11725243
    Abstract: The present invention relates to a method, in particular an in vitro method, for identifying follicular helper T cells, comprising analyzing the methylation status of at least one CpG position in the mammalian gene region for leukemia inhibitory factor (LIF), wherein a demethylation of said gene region is indicative for a follicular helper T cell, when compared to a non-follicular helper T cell. The analyses according to the invention can identify follicular helper T cells on an epigenetic level and distinguish them from all other cells in complex samples, such as, for example, other blood cells. The present invention furthermore provides an improved method for quantifying follicular helper T cells in complex samples. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: August 15, 2023
    Assignee: Precision for Medicine GmbH
    Inventors: Sven Olek, Ulrich Hoffmüller
  • Patent number: 11697842
    Abstract: Provided herein are compositions and methods for the synthesis, amplification, and in vitro transcription of full-length cDNA, or cDNA fragments. Methods are provided for reverse transcription of RNA and amplification for in vitro transcription. Further provided are method for loading of dendritic cells with the RNA and homologous lysate for immune stimulation.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: July 11, 2023
    Assignee: Baylor College of Medicine
    Inventors: William K. Decker, Vanaja Konduri
  • Patent number: 11680295
    Abstract: Disclosed are arrays of nucleic acid molecules, kits, methods of genotyping and marker assisted bovine breeding methods using SNPs on genes of the bovine interferon tau signaling pathway for improved bovine fertilization rate, or embryo survival, or both.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: June 20, 2023
    Assignee: Wisconsin Alumni Research Foundation
    Inventor: Hasan Khatib